Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital
- 22 December 2005
- journal article
- Published by Wiley in Internal Medicine Journal
- Vol. 36 (1) , 37-42
- https://doi.org/10.1111/j.1445-5994.2006.01002.x
Abstract
Background: Aminoglycoside antibiotics are commonly prescribed for the treatment of Gram‐negative infections. Appropriate dosing and therapeutic monitoring of aminoglycosides are important because these agents have a narrow therapeutic index.Aim: To audit gentamicin use at our hospital, focusing on selection of the initial dose and therapeutic monitoring practices, and to compare the results against recommendations in the existing hospital aminoglycoside guidelines, which had recently been promoted to doctors.Methods: This audit included all inpatients receiving gentamicin at The Royal Melbourne Hospital from 1 February to 12 March 2004. The principal researcher checked the drug charts of all inpatients to identify those receiving gentamicin and collected data from the medical records and the pathology database. Doses were considered ‘concordant’ if the dose given was within the recommended dosing range ±20 mg.Results: A total of 132 courses of gentamicin was included in the study. Gentamicin was prescribed for prophylaxis in 31.1% of courses. Thirty‐six per cent of patients prescribed gentamicin were more than 65 years of age. Eighty‐two per cent of the gentamicin used therapeutically was given as a single daily dose. Sixty‐six per cent of gentamicin initial dosing was not in accordance with existing hospital guidelines. Seventy‐seven per cent of gentamicin courses requiring therapeutic drug monitoring received such monitoring; however, in only 8.8% of these was the monitoring conducted according to guidelines.Conclusion: Aminoglycoside prescribing practices at our hospital are suboptimal, despite ready access to prescribing guidelines. Provision of a guideline and education sessions with doctors do not necessarily lead to widespread adoption of recommended practices. We suggest that changes to hospital systems related to prescribing and monitoring of aminoglycosides are required.Keywords
This publication has 20 references indexed in Scilit:
- Extended-Interval Aminoglycoside Administration for Children: A Meta-analysisPediatrics, 2004
- Pharmacokinetic dosing of aminoglycosides: a controlled trialThe American Journal of Medicine, 2003
- Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosidesQJM: An International Journal of Medicine, 2002
- Preventing Catheter-Related BacteriuriaArchives of internal medicine (1960), 1999
- Risk factors for toxicity in elderly patients given aminoglycosides once dailyJournal of General Internal Medicine, 1998
- A Computer-Assisted Management Program for Antibiotics and Other Antiinfective AgentsNew England Journal of Medicine, 1998
- Therapeutic drug monitoring of gentamicin: a 6‐year follow‐up auditJournal of Clinical Pharmacy & Therapeutics, 1997
- A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided dosesJournal of Antimicrobial Chemotherapy, 1996
- What is the Evidence for Once-Daily Aminoglycoside Therapy?Clinical Pharmacokinetics, 1994
- Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982Journal of Antimicrobial Chemotherapy, 1984